AU5507098A - Enhancement of dna immunization through the use of cytokines - Google Patents

Enhancement of dna immunization through the use of cytokines

Info

Publication number
AU5507098A
AU5507098A AU55070/98A AU5507098A AU5507098A AU 5507098 A AU5507098 A AU 5507098A AU 55070/98 A AU55070/98 A AU 55070/98A AU 5507098 A AU5507098 A AU 5507098A AU 5507098 A AU5507098 A AU 5507098A
Authority
AU
Australia
Prior art keywords
cytokines
enhancement
dna immunization
immunization
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55070/98A
Inventor
Kari R. Irvine
Nicholas P Restifo
Steven A Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU5507098A publication Critical patent/AU5507098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
AU55070/98A 1995-12-19 1996-12-18 Enhancement of dna immunization through the use of cytokines Abandoned AU5507098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57507295A 1995-12-19 1995-12-19
US08575072 1995-12-19
PCT/US1996/020571 WO1998008947A1 (en) 1995-12-19 1996-12-18 Enhancement of dna immunization through the use of cytokines

Publications (1)

Publication Number Publication Date
AU5507098A true AU5507098A (en) 1998-03-19

Family

ID=24298818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55070/98A Abandoned AU5507098A (en) 1995-12-19 1996-12-18 Enhancement of dna immunization through the use of cytokines

Country Status (2)

Country Link
AU (1) AU5507098A (en)
WO (1) WO1998008947A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2309766C (en) 1997-11-20 2008-09-30 Vical Incorporated Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
EP1039926A1 (en) * 1997-12-18 2000-10-04 G.D. SEARLE & CO. Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity
WO1999036089A1 (en) * 1998-01-16 1999-07-22 The Johns Hopkins University Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
CA2320223A1 (en) * 1998-02-12 1999-08-19 American Cyanamid Company Pneumococcal and meningococcal vaccines formulated with interleukin-12
JP2002502884A (en) * 1998-02-12 2002-01-29 アメリカン・サイアナミド・カンパニー Vaccine comprising interleukin-12 and herpes simplex virus antigen
AU2011203139B2 (en) * 1998-02-27 2014-06-19 The Trustees Of The University Of Pennsylvania Vaccines, immunotherapeutics and methods for using the same
US6528312B1 (en) 1998-05-06 2003-03-04 Transgene S.A. Use of G-actin for improving transfection of a polynucleotide into a cell
US6734172B2 (en) * 1998-11-18 2004-05-11 Pacific Northwest Research Institute Surface receptor antigen vaccines
WO2000041679A1 (en) * 1999-01-13 2000-07-20 Johns Hopkins University School Of Medicine Genetic immunization with co-delivery of nucleic acid and cytokines
GB9923309D0 (en) * 1999-10-01 1999-12-08 Glaxo Group Ltd Assay
AU2596901A (en) * 1999-12-21 2001-07-03 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US7388087B2 (en) * 2000-11-09 2008-06-17 The Board Of Trustees Of The University Of Illinois Enhancement of immune response to vaccine by interferon alpha
DE602004031341D1 (en) 2003-07-21 2011-03-24 Transgene Sa MULTIFUNCTIONAL CYTOKINE
ES2356154T3 (en) * 2003-07-21 2011-04-05 Transgene S.A. MULTIFUNCTIONAL CYTOKINS.
US20240115675A1 (en) * 2020-11-05 2024-04-11 Neoimmunetech, Inc. Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0714308A4 (en) * 1993-08-26 1998-07-29 Univ California Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
US5804566A (en) * 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
EP1630229B1 (en) * 1994-04-22 2013-04-03 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Melanoma antigens
CA2201592A1 (en) * 1994-10-03 1996-04-18 The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system

Also Published As

Publication number Publication date
WO1998008947A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
AU3150295A (en) Dna vaccines against rotavirus infections
AU4780596A (en) Hemi-wheeled walker
AU1209897A (en) Novel dna polymerase
AU5324196A (en) Gene transfer into the kidney
AU5040896A (en) Benzonitriles and benzofluorides
AU5507098A (en) Enhancement of dna immunization through the use of cytokines
AU4329396A (en) Use of 3,4-diphenylchromans
AU7640196A (en) Goggles
AU1050097A (en) Sequestrin
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU2698795A (en) Human chemokine beta-12
AU7457596A (en) The aiolos gene
ZA969315B (en) Processes and intermediates for the preparation of ziprasidone.
AU7694996A (en) Well fluid
AU7097696A (en) Novel human cc chemokine
ZA968873B (en) Isomerisation of equillin
ZA965709B (en) Benzylhydroxylamines and intermediates for their preparation.
AU2634095A (en) The use of an anti-helicobacter substance
AU1370397A (en) Process for the purification of recombinant human interleukin-8
AU5932296A (en) Dna encoding cellular homologue of the sv40 large t antigen
AU1205497A (en) Vaccine component
AU6623096A (en) Methods of predicting the outcome of infection
IL112916A0 (en) Modular-staircases which enable maximum use of the inner-space
AU699287B2 (en) Tube furnace